Restraint stress reduces the antitumor efficacy of cyclophosphamide in tumor-bearing mice

Brain, Behavior, and Immunity

Volumn 12, Issue 1, 1998, Pages 23-33

  Zorzet, Sonia ^a   Perissin, Laura ^b   Rapozzi, Valentina ^b   Giraldi, Tullio ^a,b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Antitumor drug; Antitumor efficacy; Cyclophosphamide; Lymphocyte subpopulations; Metastasis; Physical restraint; Psychoneuroimmunology; Stress; Tumor

Indexed keywords

CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; IMMOBILIZATION STRESS; IMMUNE RESPONSE; LEWIS CARCINOMA; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE SUBPOPULATION;

EID: 0032033943     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1997.0504     Document Type: Article

References (42)

1. Amkraut A., Solomon G. F. Stress and murine sarcoma virus (Moloney)-induced tumors. Cancer Res. 32:1972;1428-1433.
2. Ben-Efraim S., Biocian R. C., Mokyr M. B., Dray S. Increase in the effectiveness of melphalan therapy with progression of MOP-315 plasmacytoma tumor growth. Cancer Immunol. Immunother. 15:1983;101-107.
3. Berko R., Seissman K., Colvin M., Bocian R. C., Ben-Efraim S., Dray S. Tumoricidal and immunomodulatory activities of drugs and implications for therapy of mice bearing a late stage MOPC-315 plasmacytoma. Int. J. Immunopharmacol. 10:1988;825-834.
4. Brenner G. J., Cohen N., Ader R., Moynihan J. A. Increased pulmonary metastases and natural killer cell activity following handling. Life Sci. 47:1990;1813-1819.
5. Chang T. K. H., Weber G. F., Crespi C. L., Waxman D. J. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res. 45:1993;598-600.
6. Dasic G., Pacor S., Bergamo A., Salerno G., Vranesic B., Jukic R., Tomasic J., Sava G. Effects ofLLD. Int. J. Oncol. 5:1994;275-284.
7. Forsén A. Psychosocial stress as a risk for breast cancer. Psychother. Psychosom. 55:1991;176-185.
8. Frei E. III. Curative cancer chemotherapy. Cancer Res. 45:1985;6523-6537.
9. Frei E. III. Note re: Position paper on curative cancer chemotherapy. Cancer Res. 47:1987;3907-3908.
10. Giraldi T., Perissin L., Zorzet S., Piccini P., Rapozzi V. Effects of stress on tumor growth and metastasis in mice bearing Lewis lung carcinoma. Eur. J. Cancer Clin. Oncol. 25:1989;1583-1588.
11. Giraldi T., Perissin L., Zorzet S., Rapozzi V., Rodani M. G. Metastasis and neuroendocrine system in stressed mice. Int. J. Neurosci. 74:1994;265-278.
12. Giraldi T., Rodani M. G., Cartei G., Grassi L. Psychosocial factors and breast cancer: A 6-year Italian follow-up study. Psychother. Psychosom. 66:1997;229-236.
13. Giraldi T., Sava G., Cherubino R., Lassiani L., Bottiroli G., Mazzini G. Metastasis: Mitostatic drugs. The control of tumour growth and its biological bases. 1983;Akademie Verlag, Berlin. p. 55-62.
14. Greer S., Morris T., Pettingale K. W. Psychological response to breast cancer: Effect on outcome. Lancet. ii:1979;785-787.
15. Greer S., Morris T., Pettingale K. W., Haybittle J. L. Psychological response to breast cancer and 15 year outcome. Lancet. i:1990;49-50.
16. Hayden-Hixson D. M., Nemeroff C. B. Role(s)of neuropeptides in responding and adaptation to stress: A focus on corticotropin-releasing factor and opioid peptides. Atanford S. C., Salmon P. Stress: From synapse to syndrome. 1993;355-391 Academic Press, London.
17. Hengst J. C., Mokyr M. B., Dray S. Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors. Cancer Res. 41:1981;2163-2167.
18. Hunt S. U. Preparation of lymphocytes and accessory cells. Klaus C. G. B. Lymphocytes: A practical approach. 1987;1-34 IRL Press, Oxford.
19. Justice A. Review of the effects of stress on cancer in laboratory animals: Importance of time of stress application and type of tumor. Psychol. Bull. 98:1985;108-138.
20. Labarba R. C. Experimental and environmental factors in cancer. Psychosom. Med. 32:1970;258-276.
21. Lavicky J., Raskova H. Vibration stress and pharmacokinetics of rifampicin. Arzneimittelforschung. 39:1989;1240-1241.
22. Maccubbin D. L., Mace K. F., Ehrke M. J., Mihich E. Modification of host antitumor defense mechanisms in mice by progressively growing tumor. Cancer Res. 49:1989;4216-4224.
23. Mantovani A., Polentarutti N., Alessandri G., Vecchi A., Giuliani F., Spreafico F. Activation of K-cells in mice with transplanted tumors differing in immunogenicity and metastasizing capacity. Br. J. Cancer. 36:1977;453-460.
24. Milton J. D., Carpenter C. B., Addison I. E. Depressed T-cell reactivity and suppressor activity of lymphoid cells from cyclophosphamide-treated mice. Cell. Immunol. 24:1976;308-317.
25. Mokyr M. B., Dray S. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide. Cancer Res. 43:1983;3112-3119.
26. +. Cancer Res. 49:1989;4597-4606.
27. Mokyr M. B., Brundett R. B., Colvin M., Dray S. Ability of cyclophosphamide in the absence of cross-linking activity to exert the immunomodulatory effect required for the cure of mice bearing a large MOPC-315 tumor. Cancer Res. 46:1986;3313-3320.
28. Morikawa K., Hosokawa M., Hamada J., Sugawara M., Kobayashi H. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma. Cancer Res. 45:1985;1502-1506.
29. Morris T., Pettingale K., Haybittle J. Psychological response to cancer diagnosis and disease outcome in patients with breast cancer and lymphoma. Psycho-Oncology. 1:1992;105-114.
30. Moynihan J. A., Brenner G. J., Cocke R., Karp J. D., Breneman S. M., Dopp J. M., Ader R., Cohen N., Grota L. J., Felten Y. Stress-induced modulation of immune function in mice. Glaser R., Kiecolt-Glaser J. Handbook of human stress and immunity. 1994;1-22 Academic Press, San Diego.
31. Okazaki M., Eto K., Furuno K., Oishi R., Gomita Y. Influences of immobilization and footshock stress on pharmacokinetics of theophylline and caffeine in rats. J. Pharm. Pharmacol. 47:1995;530-533.
32. Page G. G., Ben-Eliyahu S., Liebeskind J. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav. Immun. 8:1994;241-250.
33. Perissin L., Zorzet S., Piccini P., Rapozzi V., Giraldi T. Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma. Clin. Exp. Metastasis. 9:1991;541-549.
34. Pettingale K. W., Morris T., Greer S., Haybittle J. L. Mental attitudes to cancer: An additional prognostic factor. Lancet. I:1985;750.
35. Pradhan S. N., Ray P. Effects of stress on growth of transplanted and 7,12-DMBA induced tumors and their modification by psychotropic drugs. J. Natl. Cancer Inst. 53:1974;1241-1245.
36. Ramirez A. J., Craig T. K. J., Watson J. P., Fentiman I. S., North W. R. S., Rubens R. D. Stress and relapse of breast cancer. Br. Med. J. 298:1989;291-293.
37. Riley V., Fitzmaurice M. A., Spackman D. H. Animal models in biobehavioral research: Effects of anxiety stress on immunocompetence and neoplasia. Weiss S. M., Herd J. A., Fox B. H. Perspective on behavioral medicine. 1981a;371-400 Academic Press, New York.
38. Riley V., Fitzmaurice M. A., Spackman D. H. Psychoneuroimmunologic factors in neoplasia: Studies in animals. Ader R. Psychoneuroimmunology. 1981b;31-102 Academic Press, New York.
39. Riley V., Spackman D., McClanahan H., Santisteban G. A. The role of stress in malignancy. Cancer Detect. Prev. 2:1979;235-255.
40. Sava G., Giraldi T., Zupi G., Sacchi A. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential. Invasion Metastasis. 4:1984;171-178.
41. Steplewski Z., Vogel W. H., Ehya H., Poropatich C., McDonald Smith J. Effects of restraint stress on inoculated tumor growth and immune response in rats. Cancer Res. 45:1985;5128-5133.
42. Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:1985;369-390.